Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
165.04
+8.39 (5.36%)
At close: Nov 13, 2026, 4:00 PM EST
165.91
+0.87 (0.53%)
After-hours: Nov 13, 2026, 7:59 PM EST
Alnylam Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $455 | Buy | Reiterates | $455 | +175.69% | Nov 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $410 | Buy | Reiterates | $410 | +148.42% | Nov 10, 2026 |
| Citi | Citi | Buy Maintains $320 → $250 | Buy | Maintains | $320 → $250 | +51.48% | Nov 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $325 → $290 | Hold | Maintains | $325 → $290 | +75.71% | Nov 6, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 5, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $290 → $292 | Buy | Reiterates | $290 → $292 | +76.93% | Nov 5, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $320 | Buy | Reiterates | $320 | +93.89% | Nov 5, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $220 | Hold | Maintains | $220 | +33.30% | Nov 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.